Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124169003 | 12416900 | 3 | F | 20160514 | 20160315 | 20160530 | 20160729 | EXP | PHHY2016MY073036 | NOVARTIS | 64.63 | YR | F | Y | 0.00000 | 20160730 | CN | COUNTRY NOT SPECIFIED | MY |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124169003 | 12416900 | 1 | PS | AFINITOR | EVEROLIMUS | 1 | Oral | 5 MG, UNK | 22334 | 5 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124169003 | 12416900 | 1 | Breast cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124169003 | 12416900 | DE |
| 124169003 | 12416900 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124169003 | 12416900 | Death | |
| 124169003 | 12416900 | Dyspnoea | |
| 124169003 | 12416900 | Lung infection | |
| 124169003 | 12416900 | Pleural effusion |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124169003 | 12416900 | 1 | 20160225 | 20160310 | 0 |